Posted on 10 February 2014. Tags: Appellate Court, food and drug administration, Infuse, Medtronic, negligence lawsuit, off-label use
Medtronic may not be a big fan of the Appellate Court these days, and with good reason. The company is back to facing a negligence lawsuit because of an off-label use of their product Infuse. The situation goes like this; a male patient underwent spinal surgery. The surgeon used Infuse. The patient went numb. A […]
Read the full story
Posted in Legal News
Posted on 11 March 2013. Tags: bumble bee tuna, chunk light tuna, chunk white albacore, FDA, food and drug administration, food safety, product recall, product safety
Bumble Bee Foods issued a voluntary recall for five-ounce cans of two of its tuna products – Chunk White Albacore and Chunk Light Tuna – on Wednesday, March 6. The recall was issued because the seals on these products do not meet the company’s standards. According to Bumble Bee, the seals on some Chunk White […]
Read the full story
Posted in Featured, Legal News, Product Safety
Posted on 20 February 2013. Tags: aids, cmv retinitus, defective medication, FDA, food and drug administration, gilead science, medical recall, product safety, vistide, voluntary recall
MedPage Today (2/19, Gever) reports that the Food and Drug Administration announced that Gilead Sciences has issued a voluntary recall for “one lot of cidofovir for intravenous infusion (Vistide),” which is used to treat cytomegalovirus (CMV) retinitis in patients with AIDS, because of some vials contain an unknown particulate. The recall “involves lot number B120217A, with an expiration […]
Read the full story
Posted in Product Safety
Posted on 20 February 2013. Tags: anti flu products, berkley body immune flu prevention, defective medication, FDA, flu treatment, food and drug administration, influenza, medication safety, online flu products, tamiflu, the flu
The Wall Street Journal (2/16, A2, Rockoff, Subscription Publication) reported that the Food and Drug Administration is warning patients to avoid so-called “generic Tamiflu” and other unapproved flu treatment products. The Journal quotes from an FDA Voice blog in which the agency’s National Health Fraud Coordinator Gary Coody said, “We want people to take effective preventive measures against […]
Read the full story
Posted in Product Safety